A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder

A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder

Abstract Background Patients with opioid use disorder (OUD) display an interindividual variability in their response to medications for opioid use disorder (MOUD). A genetic basis may explain the variability in this response. However, no consensus has been reached regarding which genetic variants si...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Caroul Chawar, Alannah Hillmer, Stephanie Sanger, Alessia D’Elia, Balpreet Panesar, Lucy Guan, Dave Xiaofei Xie, Nandini Bansal, Aamna Abdullah, Flavio Kapczinski, Guillaume Pare, Lehana Thabane, Zainab Samaan
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Opioid
Pharmacogenetic
MOUD
Methadone
GWAS
Systematic review
Medicine (General)
R5-920
Social pathology. Social and public welfare. Criminology
HV1-9960
Acceso en línea:https://doaj.org/article/5cb8c8e6c2a944c5a05ed746c8958567
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/5cb8c8e6c2a944c5a05ed746c8958567

Ejemplares similares